Craniopharyngiomas

Keyphrases

• Craniopharyngioma 100%
• Adamantinomatous 100%
• Papillary Subtype 100%
• Endocrine Disorders 50%
• Tumor 50%
• Management Options 50%
• Clinical Manifestations 50%
• Gene mutation 50%
• Systemic Chemotherapy 50%
• Bleomycin 50%
• Mortality Rate 50%
• Irradiation 50%
• Hypothalamo 50%
• Pituitary Function 50%
• Papillary 50%
• Long-term Mortality 50%
• Stereotactic Radiosurgery 50%
• Large-scale Clinical Trial 50%
• Activating mutation 50%
• Benign Tumor 50%
• High Burden 50%
• Morbidity Burden 50%
• Intracranial Tumor 50%
• Sellar 50%
• BRAF V600E 50%
• Parasellar Region 50%
• Intracystic 50%
• Suprasellar Region 50%
• BRAF Inhibitor (BRAFi) 50%
• Visual Dysfunction 50%
• Hypothalamic Dysfunction 50%
• External Irradiation 50%
• Classification Management 50%
• β-catenin Gene 50%
• Neuropsychological Dysfunction 50%

Medicine and Dentistry

• Craniopharyngioma 100%
• Clinical Trial 50%
• Neoplasm 50%
• Beta-Catenin 50%
• Mortality Rate 50%
• Gene Mutation 50%
• Intracranial Tumor 50%
• Benign Tumor 50%
• Hypothalamus Hypophysis System 50%
• Bleomycin 50%
• Stereotactic Radiosurgery 50%

Neuroscience

• Craniopharyngioma 100%
• Beta-Catenin 50%
• Gene Mutation 50%
• Face 50%
• Intracranial Tumor 50%
• Bleomycin 50%